特集: 調査項目の変更・追加が可能なセミカスタムオーダー型の調査レポート(Lucintel社)はこちら

特集 : 国別の市場調査レポートをお探しの方はこちら

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

遺伝子組み換え細胞培養サプリメントの世界市場 - タイプ・用途・地域データ・国別データ・競合情勢:分析と予測 (2019-2029年)

Global Recombinant Cell Culture Supplements Market: Focus on Product Type, Applications, 5 Regional Data, 23 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029

発行 BIS Research Inc. 商品コード 920202
出版日 ページ情報 英文 250 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.13円で換算しております。
遺伝子組み換え細胞培養サプリメントの世界市場 - タイプ・用途・地域データ・国別データ・競合情勢:分析と予測 (2019-2029年) Global Recombinant Cell Culture Supplements Market: Focus on Product Type, Applications, 5 Regional Data, 23 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029
出版日: 2019年12月13日 ページ情報: 英文 250 Pages
概要

世界の遺伝子組み換え細胞培養サプリメント市場規模は、2029年までに9億7,780万米ドルへ達すると予測されています。

当レポートでは、世界の遺伝子組み換え細胞培養サプリメント市場について取り上げ、市場ダイナミクス、競合環境、各セグメント・地域別の市場、競合状況、および主要企業などについて詳細に分析しています。

920202_Figure 3.2 Global Recombinant Cell Culture Supplements Market, 2018-2029

エグゼクティブサマリー

第1章 調査範囲

第2章 調査手法

第3章 市場概要

  • 細胞培養の基礎
  • 培地・サプリメントの役割
  • 無血清培地 vs. 血清含有培地
  • 限定培地の技術進歩および遺伝子組み換え細胞培養サプリメントの重要性
  • 遺伝子組み換え細胞培養サプリメントの市況
  • 市場規模推計の前提条件・制限事項

第4章 市場ダイナミクス

  • 影響分析
  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第5章 産業考察

  • 規制シナリオ
  • 特許情勢

第6章 競合情勢

  • 概要
  • 主な発展・戦略
  • 市場シェア分析
  • 成長シェア分析

第7章 世界の遺伝子組み換え細胞培養サプリメント市場:製品別

  • 概要
  • 遺伝子組み換えアルブミン (rAlbumin)
  • 遺伝子組み換えインスリン (rInsulin)
  • 遺伝子組み換え上皮成長因子 (rEGF)
  • 遺伝子組み換えトランスフェリン (rTransferrin)
  • 遺伝子組み換えトリプシン (rTrypsin)
  • 遺伝子組み換えインスリン様成長因子 (rIGF)
  • 遺伝子組み換え幹細胞因子 (rSCF)
  • 遺伝子組み換えアプロチニン (rAprotinin)
  • 遺伝子組み換えリゾチーム (rLysozyme)
  • その他

第8章 世界の遺伝子組み換え細胞培養サプリメント市場:用途別

  • 概要
  • 幹細胞・再生医療
  • バイオプロダクション
  • 大学・研究用途

第9章 世界の遺伝子組み換え細胞培養サプリメント市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他 (RoW)

第10章 企業プロファイル

  • 概要
  • BBI Solutions
  • Corning Incorporated
  • Evercyte GmbH
  • FUJIFILM Irvine Scientific
  • Gemini Bio-Products
  • HiMedia Laboratories
  • InVitria
  • Kingfisher Biotech, Inc.
  • Lonza Group AG
  • Merck KGaA
  • PeproTech, Inc.
  • Shenandoah Biotechnology
  • Sino Biological Inc.
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.
図表

List of Tables

  • Table 3.1: Recombinant Cell-Culture Supplements Product Offerings of Some Key Companies
  • Table 4.1: Impact Analysis of Market Dynamics
  • Table 5.1: Global Regulatory Scenario
  • Table 5.2: Patents Granted between January 2015 and October 2019
  • Table 7.1: Recombinant Albumin Products
  • Table 7.2: Global Recombinant Albumin Market (by Applications), 2018-2029
  • Table 7.3: Global Recombinant Albumin Market (by Stem Cells and Regenerative Medicine), 2018-2029
  • Table 7.4: Global Recombinant Albumin Market (by Bioproduction), 2018-2029
  • Table 7.5: Global Recombinant Insulin Market (by Applications), 2018-2029
  • Table 7.6: Global Recombinant Insulin Market (by Stem Cells and Regenerative Medicine), 2018-2029
  • Table 7.7: Global Recombinant Insulin Market (by Bioproduction), 2018-2029
  • Table 7.8: Recombinant EGF Products
  • Table 7.9: Global Recombinant EGF Market (by Applications), 2018-2029
  • Table 7.10: Global Recombinant EGF Market (by Stem Cells and Regenerative Medicine), 2018-2029
  • Table 7.11: Global Recombinant EGF Market (by Bioproduction), 2018-2029
  • Table 7.12: Recombinant Transferrin Products
  • Table 7.13: Global Recombinant Transferrin Market (by Applications), 2018-2029
  • Table 7.14: Global Recombinant Transferrin Market (by Stem Cells and Regenerative Medicine), 2018-2029
  • Table 7.15: Global Recombinant Transferrin Market (by Bioproduction), 2018-2029
  • Table 7.16: Recombinant Trypsin Products
  • Table 7.17: Global Recombinant Trypsin Market (by Application), 2018-2029
  • Table 7.18: Global Recombinant Trypsin Market (by Stem Cells and Regenerative Medicine), 2018-2029
  • Table 7.19: Global Recombinant Trypsin Market (by Bioproduction), 2018-2029
  • Table 7.20: Recombinant Trypsin Products
  • Table 7.21: Global Recombinant rIGF-I Market (by Application), 2018-2029
  • Table 7.22: Global Recombinant rIGF-I Market (by Stem Cells and Regenerative Medicine), 2018-2029
  • Table 7.23: Global Recombinant rIGF-I Market (by Bioproduction), 2018-2029
  • Table 7.24: Recombinant Trypsin Products
  • Table 7.25: Global Recombinant rSCF Market (by Application), 2018-2029
  • Table 7.26: Global Recombinant rSCF Market (by Stem Cells and Regenerative Medicine), 2018-2029
  • Table 7.27: Global Recombinant rSCF Market (by Bioproduction), 2018-2029
  • Table 7.28: Recombinant Aprotinin Products
  • Table 7.29: Global Recombinant Aprotinin Market (by Application), 2018-2029
  • Table 7.30: Global Recombinant Aprotinin Market (by Stem Cells and Regenerative Medicine), 2018-2029
  • Table 7.31: Global Recombinant Aprotinin Market (by Bioproduction), 2018-2029
  • Table 7.32: Recombinant Lysozyme Products
  • Table 7.33: Global Recombinant Lysozyme Market (by Application), 2018-2029
  • Table 7.34: Global Recombinant Lysozyme Market (by Stem Cells and Regenerative Medicine), 2018-2029
  • Table 7.35: Global Recombinant Lysozyme Market (by Bioproduction), 2018-2029
  • Table 7.36: Recombinant Other Supplement Products
  • Table 7.37: Global Recombinant Other Supplements Market (by Application), 2018-2029
  • Table 7.38: Global Recombinant Other Supplements Market (by Stem Cells and Regenerative Medicine), 2018-2029
  • Table 7.39: Global Recombinant Other Supplements Market (by Bioproduction), 2018-2029
  • Table 8.1: Companies along with Biomanufacturing Facility
  • Table 8.2: Rank 1. Vacaville Bio-Manufacturing Facility
  • Table 8.3: Rank 2. Amgen Juncos Bio-Manufacturing Facility
  • Table 8.4: Rank 3. West Greenwich Bio-Manufacturing Plant
  • Table 8.5: Rank 4. Portsmouth Bio-Manufacturing Plant
  • Table 8.6: Rank 5. Biberach Bio-Manufacturing Facility
  • Table 8.7: Rank 6. Longmont & Lake Centre Bio-Manufacturing Facility
  • Table 8.8: Rank 7. South San Francisco Bio-Manufacturing Facility
  • Table 8.9: Rank 8. Penzberg Bio-Manufacturing Facility
  • Table 8.10: Rank 9. PR05 Biotechnology Plant
  • Table 8.11: Rank 10. Devens Bio-Manufacturing Plant
  • Table 9.1: North America: Recombinant Cell Culture Supplements Market (by Product), 2019 vs 2029
  • Table 9.2: Europe Recombinant Cell Culture Supplements Market (by Product), 2018-2029
  • Table 9.3: Asia-Pacific Recombinant Cell Culture Supplements Market (by Product), 2018-2029
  • Table 9.4: Latin America Recombinant Cell Culture Supplements Market (by Product), 2018-2029
  • Table 9.5: Rest-of-the-World Recombinant Cell Culture Supplements Market (by Product), 2018-2029

List of Figures

  • Figure 1: Global Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 2: Global Recombinant Cell Culture Supplements Market (by Product), 2018 and 2029
  • Figure 3: Global Recombinant Cell Culture Supplements Market (by Application), 2018 and 2029
  • Figure 4: Global Recombinant Cell Culture Supplements Market (by Region), 2018 and 2029
  • Figure 1.1: Global Recombinant Cell Culture Supplements Market Segmentation
  • Figure 2.1: Global Recombinant Cell Culture Supplements Market Research Methodology
  • Figure 2.2: Primary Research
  • Figure 2.3: Secondary Research
  • Figure 2.4: Data Triangulation
  • Figure 2.5: Bottom-up Approach (Segment-wise Analysis)
  • Figure 2.6: Top-Down Approach (Segment-wise Anlysis)
  • Figure 2.7: Considered Factors for Data Prediction and Modelling
  • Figure 2.8: Assumptions and Limitations
  • Figure 3.1: Important Terminology
  • Figure 3.2: Global Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 3.3: Recombinant Cell Culture Supplements Market Segmentation
  • Figure 6.1: Competitive Landscape (January 2015-October 2019)
  • Figure 6.2: Share of Key Developments and Strategies, January 2015-October 2019
  • Figure 6.3: Product Launches and Developments (by Company January 2015 and October 2019
  • Figure 6.4: Collaborations, Partnerships, and Joint Ventures (by Company), January 2015 and October 2019
  • Figure 6.5: Acqusitions (by Company), January 2015 and October 2019
  • Figure 6.6: Business Expansions (by Company), January 2015 and October 2019
  • Figure 6.7: Market Share Analysis of Global Recombinant Cell Culture Supplements Market, 2018
  • Figure 6.8: Growth Share Matrix of Global Recombinant Cell Culture Supplements Market, 2018
  • Figure 7.1: Global Recombinant Cell Culture Supplements Market Segmentation (by Products)
  • Figure 7.2: Global Recombinant Cell Culture Supplements Market (by Product), 2019 vs 2029
  • Figure 7.3: Global Recombinant Albumin Market, 2018-2029
  • Figure 7.4: Global Recombinant Insulin Market, 2018-2029
  • Figure 7.5: Global Recombinant EGF Market, 2018-2029
  • Figure 7.6: Global Recombinant Transferrin Market, 2018-2029
  • Figure 7.7: Global Recombinant Trypsin Market, 2018-2029
  • Figure 7.8: Global Recombinant IGI-1 Market, 2018-2029
  • Figure 7.9: Global Recombinant Trypsin Market, 2018-2029
  • Figure 7.10: Global Recombinant Aprotinin Market, 2018-2029
  • Figure 7.11: Global Recombinant Lysozyme Market, 2018-2029
  • Figure 7.12: Global Recombinant Other Supplements Market, 2018-2029
  • Figure 8.1: Global Recombinant Cell Culture Supplements (by Application)
  • Figure 8.2: Global Recombinant Cell Culture Supplements Market (by Application), 2019 vs 2029
  • Figure 8.3: Regenerative Medicine: Present and Future
  • Figure 8.4: Global Recombinant Cell Culture Supplements Market (by Stem Cell and Regenerative Medicine), 2018-2029
  • Figure 8.5: Global Recombinant Cell Culture Supplements Market (by Stem Cell and Regenerative Medicine Application), 2019 vs 2029
  • Figure 8.6: Types of Stem cells
  • Figure 8.7: Global Recombinant Cell Culture Supplements Market (Stem Cell Therapy), 2018-2029
  • Figure 8.8: Global Recombinant Cell Culture Supplements Market (Cell Therapy), 2018-2029
  • Figure 8.9: Global Recombinant Cell Culture Supplements Market (Gene Therapy), 2018-2029
  • Figure 8.10: Global Recombinant Cell Culture Supplements Market (by Bioproduction), 2018-2029
  • Figure 8.11: Global Recombinant Cell Culture Supplements (by Bioproduction Application), 2019 vs 2029
  • Figure 8.12: Global Recombinant Cell Culture Supplements Market (Monoclonal Antibodies), 2018-2029
  • Figure 8.13: Global Recombinant Cell Culture Supplements Market (Recombinant Proteins), 2018-2029
  • Figure 8.14: Global Recombinant Cell Culture Supplements Market (Vaccines), 2018-2029
  • Figure 8.15: Global Recombinant Cell Culture Supplements Market (Hormones), 2018-2029
  • Figure 8.16: Global Recombinant Cell Culture Supplements Market (Other Biological Products), 2018-2029
  • Figure 8.17: Global Recombinant Cell Culture Supplements Market (by Academic and Research Application), 2018-2029
  • Figure 9.1: Global Cell Culture Supplements Market (by Region), 2018 vs 2029
  • Figure 9.2: Recombinant Cell Culture Supplements Market: Global Insights
  • Figure 9.3: North America: Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.4: North America: Market Dynamics
  • Figure 9.5: North America: Recombinant Cell Culture Supplements Market (by Country), 2019 vs 2029
  • Figure 9.6: U.S.: Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.7: Canada: Cell Culture Supplements Market, 2018-2029
  • Figure 9.8: Europe: Cell Culture Supplements Market, 2018-2029
  • Figure 9.9: Europe: Market Dynamics
  • Figure 9.10: Europe: Recombinant Cell Culture Supplements Market (by Country), 2019 vs 2029
  • Figure 9.11: Germany Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.12: France Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.13: The U.K. Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.14: Italy Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.15: Spain: Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.16: The Netherlands Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.17: Rest-of-Europe Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.18: Asia-Pacific Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.19: APAC: Market Dynamics
  • Figure 9.20: Asia-Pacific: Recombinant Cell Culture Supplements Market (by Country), 2019 vs 2029
  • Figure 9.21: China: Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.22: Japan: Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.23: South Korea Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.24: India Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.25: Australia Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.26: Rest-of-Asia-Pacific Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.27: Latin America Cell Culture Supplements Market, 2018-2029
  • Figure 9.28: Latin America: Market Dynamics
  • Figure 9.29: Latin America: Recombinant Cell Culture Supplements Market (by Country), 2018-2029
  • Figure 9.30: Brazil Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.31: Mexico Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.32: Rest-of-Latin America Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.33: Rest-of-the-World: Cell Culture Supplements Market, 2018-2029
  • Figure 9.34: Rest-of-the-World Recombinant Cell Culture Supplements Market (by Country), 2019 vs 2029
  • Figure 9.35: Russia Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.36: Israel: Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.37: K.S.A. Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 9.38: Others Recombinant Cell Culture Supplements Market, 2018-2029
  • Figure 10.1: Shares of Key Company Profiles
  • Figure 10.2: BBI Solutions: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.3: BBI Solutions: SWOT Analysis
  • Figure 10.4: Corning Incorporated: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.5: Corning Incorporated: Overall Financials, 2016-2018
  • Figure 10.6: Corning Incorporated: Revenue (by Segment), 2016-2018
  • Figure 10.7: Corning Incorporated: Revenue (by Region), 2016-2018
  • Figure 10.8: Corning Incorporated: R&D Expenditure (2016-2018)
  • Figure 10.9: Corning Incorporated: SWOT Analysis
  • Figure 10.10: Evercyte GmbH: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.11: Evercyte GmbH: SWOT Analysis
  • Figure 10.12: FUJIFILM Irvine Scientific: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.13: FUJIFILM Irvine Scientific: SWOT Analysis
  • Figure 10.14: Gemini Bio-Products: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.15: Gemini Bio-Products: SWOT Analysis
  • Figure 10.16: HiMedia Laboratories: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.17: HiMedia Laboratories: SWOT Analysis
  • Figure 10.18: InVitria: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.19: InVitria: SWOT Analysis
  • Figure 10.20: Kingfisher Biotech, Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.21: Kingfisher Biotech, Inc.: SWOT Analysis
  • Figure 10.22: Lonza Group AG: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.23: Lonza Group AG: Overall Financials, 2016-2018
  • Figure 10.24: Lonza Group AG: Revenue (by Segment), 2016-2018
  • Figure 10.25: Lonza Group AG: Revenue (by Region), 2016-2018
  • Figure 10.26: Lonza Group AG: R&D Expenditure (2016-2018)
  • Figure 10.27: Lonza Group AG: SWOT Analysis
  • Figure 10.28: Merck KGaA: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.29: Merck KGaA: Overall Financials, 2016-2018
  • Figure 10.30: Merck KGaA: Revenue (by Segment), 2016-2018
  • Figure 10.31: Merck KGaA: Revenue (by Region), 2016-2018
  • Figure 10.32: Merck KGaA: R&D Expenditure (2016-2018)
  • Figure 10.33: Merck KGaA: SWOT Analysis
  • Figure 10.34: PeproTech, Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.35: PeproTech, Inc.: Recombinant Proteins for Cell Culture under Growth Factor and Cytokines Segment
  • Figure 10.36: PeproTech, Inc.: SWOT Analysis
  • Figure 10.37: Shenandoah Biotechnology: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.38: Shenandoah Biotechnology: SWOT Analysis
  • Figure 10.39: Sino Biological Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.40: Sino Biological Inc.: SWOT Analysis
  • Figure 10.41: STEMCELL Technologies Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.42: STEMCELL Technologies Inc.: SWOT Analysis
  • Figure 10.43: Thermo Fisher Scientific Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 10.44: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
  • Figure 10.45: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 10.46: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
  • Figure 10.47: Thermo Fisher Scientific Inc.: R&D Expenditure (2016-2018)
  • Figure 10.48: Thermo Fisher Scientific Inc.: SWOT Analysis
目次
Product Code: BH074B

"Global Recombinant Cell Culture Supplements Market to Reach $977.8 Million by 2029."

Key Questions Answered in this Report:

  • What is the role of media and supplements in cell culture and what are the advantages associated with serum-free media? What is the importance of recombinant proteins in cell culture applications?
  • What are the key trends of the global recombinant cell culture supplements market? How is the market evolving and what is its future scope?
  • What are the major drivers, challenges, and opportunities of the global recombinant cell culture supplements market?
  • What are the key developmental strategies implemented by the key players of the global recombinant cell culture supplements to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
  • What is the regulatory scenario of the global recombinant cell culture supplements market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of recombinant cell culture supplements products?
  • What was the market size of the global recombinant cell culture supplements market in 2018 and what is the market size anticipated to be in 2029? What is the expected growth rate of the global recombinant cell culture supplements market during the period between 2019 and 2029?
  • What are the different recombinant supplement products involved in cell culture? Which product type dominate the market in 2018 and why? Which product type are expected to witness highest growth rate and to dominate in market in 2029?
  • What are the different application areas of the global recombinant cell culture supplements market? Which application type dominates the market in 2018 and is expected to dominate in 2029?
  • What was the market value of the leading segments and sub-segments of the global recombinant cell culture supplements market? What are the different macro and micro factors influencing the growth of the market?
  • Which region is expected to contribute the highest sales of the global recombinant cell culture supplements market during the period between 2018 and 2029? Which region and country carries the potential for the significant expansion of key companies for different recombinant cell culture supplement products? What are the leading countries of different regions that contribute significantly toward the growth of the recombinant cell culture supplements market?
  • What are the key players of the global recombinant cell culture supplements market and what is their role in the market?

Global Recombinant Cell Culture Supplements Market Forecast, 2019-2029

The recombinant cell culture supplements market analysis by BIS Research projects the market to grow at a significant CAGR of 12.93% during the forecast period, 2019-2029. The recombinant cell culture supplements market generated $258.8 million revenue in 2018, in terms of value.

The recombinant cell culture supplements market growth has been primarily attributed to the major drivers in this market such as advantages offered by recombinant cell culture supplements and the promising impact displayed by them in culturing cells act as drivers for the growth of the market. Moreover, an increase in funding and investment supporting the advancement of life-science research with an ever-increasing demand for advanced cell culture systems have boosted the adoption rate of recombinant cell-culture supplements products. However, there are significant challenges which are restraining the market growth. These challenges include the shortage of skilled professionals and lack of proper laboratory infrastructure. Further, high cost of the cell culturing process and complications involved in it are also acting as challenge for the market.

Expert Quote

"The most important advantage of utilizing these recombinant proteins is that they facilitate large batch biomanufacturing with minimal risk of contamination and improved adhesion. Another advantage is that it involves animal-free manufacturing which in turn simplifies regulatory issues and export-import issues."

Scope of the Market Intelligence on Recombinant Cell Culture Supplements Market

The recombinant cell culture supplements market report provides a holistic view of the market in terms of various factors influencing it, including product optimization, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global recombinant cell culture supplements market.

Market Segmentation

The recombinant cell culture supplements market segmentation (on the basis of product) is further segmented into recombinant insulin, transferrin, albumin, among others.

The recombinant cell culture supplements market segmentation (on the basis of application) is segmented into stem cell and regenerative medicine, bio-production, and academic and research.

The recombinant cell culture supplements market segmentation (on the basis of region) is segmented into North America, Europe, Asia-Pacific, Latin America and Rest-of-the-World.

Key Companies in the Recombinant Cell Culture Supplements Market

The key manufacturers who have been contributing significantly to the Recombinant Cell Culture Supplements Market include Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Hi-Media Laboratories, Sartorius AG, InVitro, SeraCare Life Sciences, Inc., GE Healthcare, Novozymes A/S, and Advanced Biotechnologies, Inc., among others.

Table of Contents

Executive Summary

1 Scope of the Work

  • 1.1 Overview: Report Scope
  • 1.2 Segmentation of the Global Recombinant Cell Culture Supplements Market
  • 1.3 Assumptions and Limitations
  • 1.4 Key Questions Answered in the Report
  • 1.5 Base Year and Forecast Period

2 Research Methodology

  • 2.1 Overview: Report Methodology

3 Market Overview

  • 3.1 Fundamentals of Cell Culture
  • 3.2 Role of Media and Supplements
  • 3.3 Serum-free Media vs. Serum containing Media
  • 3.4 Technological Advancements of Defined Media and Importance of Recombinant Cell Culture Supplements
  • 3.5 Recombinant Cell Culture Supplements Market Scenario
  • 3.6 Assumptions and Limitations for Market Size Calculations

4 Market Dynamics

  • 4.1 Impact Analysis
  • 4.2 Market Drivers
    • 4.2.1 Benefits of Using Recombinant Cell Culture Supplements
    • 4.2.2 Increase in Funding and Investment in R&D of Life Science Sector
    • 4.2.3 Rising Demand for Advanced Cell Culture Products
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Cell Biology Research
    • 4.3.2 Technical Considerations Associated with Cell Culture
    • 4.3.3 Lack of Infrastructure and Skilled Professionals for Cell-based Research
  • 4.4 Market Opportunities
    • 4.4.1 Rising Demand for Monoclonal Antibodies and Stem Cell Research
    • 4.4.2 Increasing Preference for Serum-Free Media

5 Industry Insights

  • 5.1 Regulatory Scenario
  • 5.2 Patent Landscape

6 Competitive Landscape

  • 6.1 Overview
  • 6.2 Key Developments and Strategies
    • 6.2.1 Product Launch and Development
    • 6.2.2 Collaborations, Partnerships, and Joint Ventures
    • 6.2.3 Acquisitions
    • 6.2.4 Business Expansions
    • 6.2.5 Others
  • 6.3 Market Share Analysis
  • 6.4 Growth Share Analysis

7 Global Recombinant Cell Culture Supplements Market (by Products)

  • 7.1 Overview
  • 7.2 Recombinant Albumin (rAlbumin)
  • 7.3 Recombinant Insulin (rInsulin)
  • 7.4 Recombinant Epidermal Growth Factor (rEGF)
  • 7.5 Recombinant Transferrin (rTransferrin)
  • 7.6 Recombinant Trypsin (rTrypsin)
  • 7.7 Recombinant Insulin-like Growth Factor (rIGF)
  • 7.8 Recombinant Stem Cell Factor Protein (rSCF)
  • 7.9 Recombinant Aprotinin (rAprotinin)
  • 7.10 Recombinant Lysozyme (rLysozyme)
  • 7.11 Others

8 Global Recombinant Cell Culture Supplements Market (by Application)

  • 8.1 Overview
  • 8.2 Stem Cell and Regenerative Medicine
    • 8.2.1 Stem Cell Therapy
    • 8.2.2 Cell Therapy
    • 8.2.3 Gene Therapy
  • 8.3 Bioproduction
    • 8.3.1 Monoclonal Antibodies
    • 8.3.2 Recombinant Proteins
    • 8.3.3 Vaccines
    • 8.3.4 Hormones
    • 8.3.5 Other Biological Products
  • 8.4 Academic and Research Application

9 Global Recombinant Cell Culture Supplements Market (by Region)

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 Overview
    • 9.2.2 U.S.
    • 9.2.3 Canada
  • 9.3 Europe
    • 9.3.1 Overview
    • 9.3.2 Germany
    • 9.3.3 France
    • 9.3.4 U.K.
    • 9.3.5 Italy
    • 9.3.6 Spain
    • 9.3.7 The Netherlands
    • 9.3.8 Rest-of-Europe
  • 9.4 Asia-Pacific
    • 9.4.1 Overview
    • 9.4.2 China
    • 9.4.3 Japan
    • 9.4.4 South Korea
    • 9.4.5 India
    • 9.4.6 Australia
    • 9.4.7 Rest-of-Asia-Pacific
  • 9.5 Latin America
    • 9.5.1 Overview
    • 9.5.2 Brazil
    • 9.5.3 Mexico
    • 9.5.4 Rest-of-Latin America
  • 9.6 Rest-of-the-World
    • 9.6.1 Overview
    • 9.6.2 Russia
    • 9.6.3 Israel
    • 9.6.4 Kingdom of Saudi Arabia (K.S.A.)
    • 9.6.5 Others

10 Company Profiles

  • 10.1 Overview
  • 10.2 BBI Solutions
    • 10.2.1 Company Overview
    • 10.2.2 Role of BBI Solutions in the Global Recombinant Cell Culture Supplements Market
    • 10.2.3 SWOT Analysis
  • 10.3 Corning Incorporated
    • 10.3.1 Company Overview
    • 10.3.2 Role of Corning Incorporated in the Global Recombinant Cell Culture Supplements Market
    • 10.3.3 Financials
    • 10.3.4 SWOT Analysis
  • 10.4 Evercyte GmbH
    • 10.4.1 Company Overview
    • 10.4.2 Role of Evercyte GmbH in the Global Recombinant Cell Culture Supplements Market
    • 10.4.3 SWOT Analysis
  • 10.5 FUJIFILM Irvine Scientific
    • 10.5.1 Company Overview
    • 10.5.2 Role of FUJIFILM Irvine Scientific in the Global Recombinant Cell Culture Supplements Market
    • 10.5.3 SWOT Analysis
  • 10.6 Gemini Bio-Products
    • 10.6.1 Company Overview
    • 10.6.2 Role of Gemini Bio-Products in the Global Recombinant Cell Culture Supplements Market
    • 10.6.3 SWOT Analysis
  • 10.7 HiMedia Laboratories
    • 10.7.1 Company Overview
    • 10.7.2 Role of HiMedia Laboratories in the Global Recombinant Cell Culture Supplements Market
    • 10.7.3 SWOT Analysis
  • 10.8 InVitria
    • 10.8.1 Company Overview
    • 10.8.2 Role of InVitria in the Global Recombinant Cell Culture Supplements Market
    • 10.8.3 SWOT Analysis
  • 10.9 Kingfisher Biotech, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Role of Kingfisher Biotech, Inc. in the Global Recombinant Cell Culture Supplements Market
    • 10.9.3 SWOT Analysis
  • 10.10 Lonza Group AG
    • 10.10.1 Company Overview
    • 10.10.2 Role of Lonza Group AG in the Global Recombinant Cell Culture Supplements Market
    • 10.10.3 Financials
    • 10.10.4 SWOT Analysis
  • 10.11 Merck KGaA
    • 10.11.1 Company Overview
    • 10.11.2 Role of Merck KGaA in the Global Recombinant Cell Culture Supplements Market
    • 10.11.3 Financials
    • 10.11.4 SWOT Analysis
  • 10.12 PeproTech, Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Role of PeproTech, Inc. in the Global Recombinant Cell Culture Supplements Market
    • 10.12.3 SWOT Analysis
  • 10.13 Shenandoah Biotechnology
    • 10.13.1 Company Overview
    • 10.13.2 Role of Shenandoah Biotechnology in the Global Recombinant Cell Culture Supplements Market
    • 10.13.3 SWOT Analysis
  • 10.14 Sino Biological Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Role of Sino Biological Inc. in the Global Recombinant Cell Culture Supplements Market
    • 10.14.3 SWOT Analysis
  • 10.15 STEMCELL Technologies Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Role of STEMCELL Technologies Inc. in the Global Recombinant Cell Culture Supplements Market
    • 10.15.3 SWOT Analysis
  • 10.16 Thermo Fisher Scientific Inc.
    • 10.16.1 Company Overview
    • 10.16.2 Role of Thermo Fisher Scientific Inc. in the Global Recombinant Cell Culture Supplements Market
    • 10.16.3 Financials
    • 10.16.4 SWOT Analysis